Valproic acid and sleep apnoea: A disproportionality signal from the WHO pharmacovigilance database-Reference-Cited by-同舟云学术

Valproic acid and sleep apnoea: A disproportionality signal from the WHO pharmacovigilance database

Published:2020-01-30 Issue:3 Volume:25 Page:336-338
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:Respirology

Author:

Revol Bruno¹²³^ORCID,Jullian‐Desayes Ingrid¹²^ORCID,Guichard Kelly⁴⁵⁶,Micoulaud‐Franchi Jean‐Arthur⁴⁵⁶,Tamisier Renaud¹²,Philip Pierre⁴⁵⁶,Joyeux‐Faure Marie¹²,Pépin Jean‐Louis¹²^ORCID

Affiliation:

1. HP2 Inserm U1042Université Grenoble Alpes Grenoble France

2. Laboratoire EFCRCHU Grenoble Alpes Grenoble France

3. Centre Régional de PharmacovigilanceCHU Grenoble Alpes Grenoble France

4. Clinique du SommeilCHU de Bordeaux Bordeaux France

5. SANPSYUniversité de Bordeaux Bordeaux France

6. SANPSY USR 3413CNRS Bordeaux France

Funder

Agence Nationale de la Recherche

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/resp.13771

Reference10 articles.

1. Adverse drug reactions induced by valproic acid

2. Effect of sodium valproate on the sleep structures of epileptic patients

3. Gabapentinoids and sleep apnea syndrome: a safety signal from the WHO pharmacovigilance database

4. Gabapentin acutely increases the apnea-hypopnea index in older men: data from a randomized, double-blind, placebo-controlled study

5. Severe Central Sleep Apnea Associated With Chronic Baclofen Therapy

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reversible central respiratory events induced by valproic acid treatment: A case report;SAGE Open Medical Case Reports;2024-01

2. Comment intégrer les données massives dans la pratique du pneumologue : le syndrome d’apnées du sommeil comme cas d’usage;Revue des Maladies Respiratoires Actualités;2021-04

3. Anti-epileptic medications;Side Effects of Drugs Annual;2021